Dont count them out yet. Iam wishing the next PR or 2 announcing a Joint Venture agreement!!
Perhaps even more interesting, is the fact that we have yet to hear about Mentor or Allergen on this matter. These companies together represent 81% of the breast implant market, and currently have no competing technologies in development. Knowing the FDA’s new requirements, as well as the cost associated with developing a technology like VeriTeQ’s, it would seem logical that VeriTeQ could begin to receive interest from these major players in the implantation market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.